| Observational Study of the Efficacy and Safety of Anlotinib Combined With Penpulimab in Elderly Lung Cancer Patients (NCT05319886) | The First Affiliated Hospital of Xinxiang Medical College | 2022-05-16 |
| Serum Exosomal miRNA Predicting the Therapeutic Efficiency in Lung Squamous Carcinoma (NCT05854030) | Tianjin Medical University Cancer Institute and Hospital | 2022-04-01 |
| A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in China (NCT05337163) | Creative Biosciences (Guangzhou) Co., Ltd. | 2022-02-25 |
| Home-based Exercise Training for Lung Cancer Patients Awaiting Surgery (NCT05473052) | Instituto Politécnico de Leiria | 2022-02-01 |
| (HARMONY) Study of BLU-701 in EGFR-mutant NSCLC (NCT05153408) | Blueprint Medicines Corporation | 2022-01-13 |
| Comprehensive Care Program for Their Return to Normal Life Among Lung Cancer Survivors (NCT05078918) | Samsung Medical Center | 2021-09-08 |
| Feasibility of Mobile-CT-Assisted Bronchoscopy for the Diagnosis of Lung Lesion (NCT04995172) | M.D. Anderson Cancer Center | 2021-04-19 |
| LUS to Assess Lung Injury After Lung Lobectomy (NCT04755478) | Hospital General Universitario de Valencia | 2021-01-28 |
| Lung Ultrasound to Assess Aeration Loss After Lung Resection Surgery (NCT04677309) | Ana Broseta Lleó | 2020-12-20 |
| The Efficacy of Intraoperative Pulmonary Nodules Localization Guided by Virtual Reality Technology (NCT04529603) | Ruijin Hospital | 2020-12-01 |
| External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLC (NCT04697446) | Blueprint Medicines Corporation | 2020-12-01 |
| Feasibility Study of Anatomical Modeling for Image Guided Thoracic Surgery (NCT05046067) | M.D. Anderson Cancer Center | 2020-09-16 |
| Significance of Early Mobilization After VATS-L (NCT04508270) | Rigshospitalet, Denmark | 2020-09-08 |
| Camrelizumab Combined With Apatinib, Etoposide and Cisplatin Treat Small-cell Lung Cancer. (NCT04490421) | Fuzhou General Hospital | 2020-08-01 |
| A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) (NCT04222972) | Hoffmann-La Roche | 2020-07-24 |
| Comparison of Imaging Characteristics of uEXPLORER and Conventional PET/CT in Patients With Lung Cancer, Lymphoma, and Melanoma (NCT04478318) | University of California, Davis | 2020-06-01 |
| Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1) (NCT04281784) | University of Washington | 2020-04-23 |
| Brazilian Lung Immunotherapy Study (NCT05081674) | Hospital Israelita Albert Einstein | 2020-01-01 |
| Prophylactic Risedronate for Patients With Peripheral Lung Tumors Treated With SBRT (NCT03861091) | Wake Forest University Health Sciences | 2019-07-12 |
| Facilitating Communication Study (NCT03721952) | University of Washington | 2019-04-17 |
| Multiplex Analysis of Circulating Tumor DNA (NCT03301961) | Peking University People's Hospital | 2019-04-11 |
| The Use of Artificial Intelligence to Predict Cancerous Lymph Nodes for Lung Cancer Staging During Ultrasound Imaging (NCT03849040) | St. Joseph's Healthcare Hamilton | 2019-04-08 |
| The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study (NCT04075305) | UMC Utrecht | 2019-02-01 |
| Efficacy and Safety of Anlotinib as Maintenance Treatment After First-line Chemotherapy in SCLC (NCT03780283) | First Hospital of Shijiazhuang City | 2019-01-01 |
| Anlotinib Plus Sintilimab for NSCLC Patients With First-generation EGFR-TKIs Drug Resistance Along With T790M Negative (NCT03765775) | First Hospital of Shijiazhuang City | 2018-11-20 |
| Circulating Tumor DNA Longitudinal Monitoring in Stage III-IV Lung Cancer Patients (NCT03664843) | First Hospital of Shijiazhuang City | 2018-11-09 |
| Patient-derived Organoid Model and Circulating Tumor Cells for Treatment Response of Lung Cancer (NCT03655015) | The University of Texas Health Science Center at San Antonio | 2018-10-16 |
| Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer (PROVE) (NCT03090880) | Assistance Publique - Hôpitaux de Paris | 2018-09-14 |
| COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors. (NCT03667716) | Compugen Ltd | 2018-09-06 |
| Immune Checkpoint Inhibitors in Advanced Non-small Cell Lung Cancer and Discovery of New Biomarkers (NCT03658460) | Aalborg University Hospital | 2018-08-22 |
| Monitoring of Circulating Tumor DNA and Its Aberrant Methylation in the Surveillance of Surgical Lung Cancer Patients (MEDAL, MEthylation Based Dynamic Analysis for Lung Cancer). (NCT03634826) | Peking University People's Hospital | 2018-08-15 |
| Trial of Identifying the Lung Intersegmental Plane by Iron Sucrose Injection Staining (NCT03516500) | Ruijin Hospital | 2018-05-09 |
| Radial-Probe Endobronchial Ultrasound in Detecting Atelectasis in Patients Undergoing Peripheral Bronchoscopy (NCT03523689) | M.D. Anderson Cancer Center | 2018-04-30 |
| Cardiovascular Morbidities and Lung Cancer Treatment: a Prospective Registry (NCT03368820) | European Lung Cancer Working Party | 2017-12-04 |
| Early Diagnosis of Small Pulmonary Nodules by Multi-omics Sequencing (NCT03320044) | Peking University People's Hospital | 2017-10-18 |
| Assessment of Functional Capacity, Pain, Cognitive and Respiratory Functions in Lung Cancer Survivors (NCT04431921) | Hacettepe University | 2017-07-17 |
| PATHOS Study Pain Assessment in Thoracic Oncologic Surgery (NCT03134729) | IRCCS Sacro Cuore Don Calabria di Negrar | 2017-05-04 |
| Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy (NCT02984761) | VA Office of Research and Development | 2017-04-13 |
| Preoperative Loading With Carbohydrates in Lung Cancer Surgery (NCT03070626) | Oslo University Hospital | 2017-03-20 |
| Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors (NCT03037385) | Hoffmann-La Roche | 2017-03-17 |
| Application of 3D Printing Technique in Small Pulmonary Nodule Localization (NCT02952261) | Chang Chen | 2016-10-24 |
| Symptom Burden and Unmet Supportive Care Needs in Lung Cancer Patients Undergoing First or Second Line Immunotherapy (NCT03741868) | Wake Forest University Health Sciences | 2016-10-16 |
| The Value of VOCs Analysis in Exhaled Breath for Pulmonary Benign and Malignant Lesion Diagnosis (NCT02965300) | Chinese PLA General Hospital | 2016-10-01 |
| Single-port, Two-port Versus Three-port VATS on Non-small Cell Lung Cancer (NCT02992353) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2016-07-01 |
| RCT Comparing 19Ga vs 22Ga EBUS-TBNA Needles in Carcinoma. (NCT02906280) | KU Leuven | 2016-05-01 |
| HA-WBRT-SIB for Brain Metastasis of Lung Cancer (NCT06289023) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2016-01-01 |
| Efficacy and Safety of Adjuvant Pemetrexed Plus Cisplatin for Adenocarcinoma of Lung (NCT02498860) | Chonnam National University Hospital | 2015-09-01 |
| An Integrated Approach to Treating Recurrent Thoracic Carcinomas Resistant to Tyrosine Kinase Inhibitors (NCT02616211) | Mayo Clinic | 2014-10-01 |
| Safety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the Elderly (NCT02151149) | Celgene | 2014-06-09 |
| Biomarkers for Diagnosis of Lung Cancer (NCT02050100) | SK Medical (Beijing) Co., Ltd. | 2014-01-01 |
| Engagement of Patients With Advanced Cancer (NCT02966509) | Stanford University | 2013-08-01 |
| Assessing the Patient Experience in Cancer Care (NCT01621295) | Mayo Clinic | 2012-05-01 |
| Respiratory Endoscopy: Diagnostic Yield, Technical Factors and Complications (NCT01374542) | Singapore General Hospital | 2011-06-01 |
| Reader Study of DeltaView™ Chest Radiograph Software (NCT01261507) | Georgetown University | 2010-11-01 |
| False/Negative Rate of Lung Percutaneous Needle Biopsy (NCT00638352) | State University of New York - Upstate Medical University | 2010-03-01 |
| Meditation-Based Breathing Training in Improving Target Motion Management and Reducing Distress in Patients With Abdominal or Lung Cancer Undergoing Radiation Therapy (NCT01939210) | Albert Einstein College of Medicine | 2010-02-01 |
| Correlation of X-ray and Pathology With Needle Biopsy of Lung Tumors (NCT00638625) | State University of New York - Upstate Medical University | 2010-01-01 |
| Evaluation of the LungPoint Virtual Bronchoscopic Navigation (VBN) System (NCT01067755) | Broncus Technologies | 2009-07-01 |
| Hypofractionated Radiotherapy for Limited Stage Small Cell Lung Cancer (NCT00907569) | AHS Cancer Control Alberta | 2009-06-01 |
| Role of a Silicone Prosthesis to Prevent Airway Obstruction Recurrence in Lung Cancers (NCT01064050) | Centre Hospitalier Universitaire de Saint Etienne | 2008-11-01 |
| Pilot Study of 18F-FAZA in Assessing Early Functional Response in Patients With Inoperable Non Small Cell Lung Cancer Undergoing Radiotherapy or Chemo-radiotherapy (NCT00765986) | AHS Cancer Control Alberta | 2008-10-01 |
| Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy (NCT00676507) | NovaRx Corporation | 2008-07-01 |
| Cone Beam CT Scanning in Lung and Bladder Cancer. (NCT00469066) | AHS Cancer Control Alberta | 2007-05-01 |
| Oral Vinorelbine and Cisplatin and Concurrent Radiotherapy After Induction Chemotherapy in Locally Advanced NSCLC. (NCT00295672) | University Hospital, Brest | 2006-02-01 |
| Collection and Storage of Blood and Tissue Samples From Patients Who Are Undergoing Surgery For Lung Cancer (NCT00899782) | Alliance for Clinical Trials in Oncology | 2004-07-15 |
| Phase II Study of Lucanix™ in Patients With Stages II-IV Non-Small Cell Lung Cancer (NCT01058785) | NovaRx Corporation | 2003-03-01 |
| An Open Label Study of a Peptide Vaccine in Patients With Stage IIb or IIIa Non-Small Cell Lung Cancer (NCT00054899) | Epimmune | 2003-01-01 |
| Safety and Tolerability Study of TAK-165 in Subjects With Tumors Expressing HER2 (NCT00034281) | Takeda | 2002-06-01 |
| Combination Therapy of Interleukin-12 and Interleukin-2 to Treat Advanced Cancer (NCT00005655) | National Cancer Institute (NCI) | 2000-04-28 |